Counterscreen for antagonists of galanin receptor 2 (GalR2): a cell-based high-throughput screening assay for inhibitors of beta-lactamase activity Chinese Hamster Ovary (CHO) cells stably transfected with NFAT-BLA were routinely cultured in T-175 sq cm flasks at 37 degrees C and 95% relative humidity (RH). The growth media consisted of Dulbecco's Modified Eagle's Media (DMEM) supplemented with 10% v/v heat-inactivated dialyzed fetal bovine serum, 0.1 mM NEAA, 1 mM Sodium Pyruvate, 25 mM HEPES, GlutaMAX-I Supplement, 0.1 mg/mL Zeocin, and 1X antibiotic mix (penicillin, streptomycin, and neomycin). Prior to the start of the assay, cells were suspended at a concentration of 0.5 million/mL in assay media (growth media as above but without Zeocin). Next, 4 ul of cell suspension were dispensed to each test well of 1536-well plates (2000 cells/well) followed by incubation at 25 degrees C in 5% CO2 for 1 hour. Following the incubation, the assay was started by dispensing 21 nL of test compound in DMSO (4 uM final nominal concentration; 0.4% final DMSO concentration) or DMSO only (for negative control wells) to the appropriate wells. Then, 1 ul of thapsigargin in 2% BSA (final concentration of 500 nM, a concentration that resulted in approximately 100% activity) was dispensed to sample field wells. Next, the high control (500 nM thapsigargin in 2% BSA) and low control (2% BSA) were dispensed to the appropriate control wells and the plates were incubated at 37 degrees C in 5% CO2 for 4 hours. After the incubation, the fluorogenic LiveBLAzer substrate mixture with 10 mM Probenicid was prepared according to the manufacturer's protocol and 1 ul was added to each well. After a further 2 hours of incubation at 25 degrees C, well fluorescence was measured at 405 nm excitation wavelength and emission wavelengths of 535 nm and 460 nm using the EnVision plate reader (PerkinElmer Life Sciences, Turku, Finland). Prior to normalization, fluorescence values measured for each channel were corrected by subtracting "background" fluorescence, i.e. fluorescence measured in wells containing media and substrate only. To normalize assay data, values measured from the probe's fluorescence emission wavelengths were used to calculate a ratio for each well, according to the following mathematical expression: Ratio = I460 nm/I535 nm where I represents the measured fluorescence emission intensity at the enumerated wavelength in nanometers. Percent inhibition was calculated from the median ratio as follows: % Inhibition= ((Ratio_Test_Compound-Median_Ratio_High_Control) / (Median_Ratio_Low_Control - Median_Ratio_High_Control))*100 Where: Test_Compound is defined as wells containing test compound Low_Control is defined as wells containing 1 ul of 2% BSA in PBS High_Control is defined as wells containing 1 ul of 2.5 uM thapsigargin in 2% BSA. A mathematical algorithm was used to determine nominally inhibiting compounds in the primary screen. Two values were calculated: (1) the average percent inhibition of all compounds tested, and (2) three times their standard deviation. The sum of these two values was used as a cutoff parameter, i.e. any compound that exhibited greater % inhibition than the cutoff parameter was declared active. The reported Pubchem_Activity_Score has been normalized to 100% observed primary inhibition. Negative % inhibition values are reported as activity score 0. List of reagents: Dulbecco's Modified Eagle's Media I (Invitrogen, part 10566-024) Fetal Bovine Serum (Hyclone, part SH30079.03) NEAA (Invitrogen, part 1114-050) Sodium Pyruvate (Invitrogen, part 11360-070) HEPES (Invitrogen, part 15630-080) Zeocin (Invitrogen, part R250-01) 100X Penicillin-Streptomycin-Neomycin mix (Invitrogen, part 15640-055). Fatty Acid-Free Bovine Serum Albumin (Calbiochem, part 126609) PBS (Invitrogen, part 10010-023) Probenicid (Sigma, part P8761) LiveBLAzer (Invitrogen, part K1096) Thapsigargin (Sigma, part T9033)
bao:BAO_0000541 "828" ; # "is counter assay of" -> "828"
bao:BAO_0000812 "1668" ; # "has summary assay" -> "1668"
bao:BAO_0000210 bao:BAO_0000032 ; # "has assay stage" -> "secondary assay"
bao:BAO_0001070 bao:BAO_0001064 ; # "has alternate target assay" -> "alternate target assay"
bao:BAO_0000205 bao:BAO_0000219 ; # "has assay format" -> "cell-based format"
bao:BAO_0000409 bao:BAO_0000410 ; # "assay measurement type" -> "endpoint assay"
bao:BAO_0002850 bao:BAO_0000534 ; # "has assay readout content" -> "single readout"
bao:BAO_0002851 "single parameter" ; # "has assay readout content parametricity" -> "single parameter"
bao:BA0_0090012 bao:BAO_0000287 ; # "has participant" -> "hydrolase" || bao:BAO_0003102 bao:BAO_00020144 ; # "has role" -> "target"
bao:BAO_0002855 "beta lactamase reporter gene" ; # "is bioassay type of" -> "beta lactamase reporter gene"
bao:BAO_0000212 bao:BAO_0000125 ; # "has assay method" -> "reporter gene method"
bao:BAO_0000212 bao:BAO_0000151 ; # "has assay method" -> "beta lactamase induction"
bao:BAO_0000207 bao:BAO_0000001 ; # "has detection method" -> "fluorescence resonance energy transfer"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Antagonists of the galanin receptor 2 (Gal2)" ; # "screening campaign name" -> "Antagonists of the galanin receptor 2 (Gal2)"
bao:BAO_0002853 "Counterscreen for antagonists of galanin receptor 2 (GalR2): a cell-based high-throughput screening assay for inhibitors of beta-lactamase activity" ; # "has assay title" -> "Counterscreen for antagonists of galanin receptor 2 (GalR2): a cell-based high-throughput screening assay for inhibitors of beta-lactamase activity"
bao:BAO_0002854 bao:BAO_0000010 ; # "has bioassay type" -> "functional"
bao:BAO_0002867 bao:BAO_0000516 ; # "has assay footprint" -> "1536 well plate"
bao:BAO_0002863 bao:BAO_0000536 ; # "has concentration throughput" -> "single concentration"
bao:BAO_0000109 "37 degree celsius" ; # "has temperature value" -> "37 degree celsius"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "25 degree celsius" ; # "substrate incubation temperature" -> "25 degree celsius"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "2 hour" ; # "substrate incubation time" -> "2 hour"
bao:BAO_0002833 "4 hour" ; # "has incubation time value" -> "4 hour"
bao:BAO_0002857 "\"Thapsigargin 500 nanomolar, PBS\"" ; # "has signal direction" -> ""Thapsigargin 500 nanomolar, PBS""
bao:BAO_0000740 bao:BAO_0000156 ; # "has assay control" -> "high signal control"
bao:BAO_0002857 "PBS" ; # "has signal direction" -> "PBS"
bao:BAO_0000740 bao:BAO_0000168 ; # "has assay control" -> "low signal control"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Steven Brown" ; # "material entity assay provider" -> "Steven Brown" || bao:BAO_0003102 bao:BAO_0000027 ; # "has role" -> "assay provider"
bao:BAO_0002020 bao:BAO_0000373 ; # "has assay phase characteristic" -> "heterogeneous phase"
bao:BAO_0000118 "0.40%" ; # "DMSO" -> "0.40%"
bao:BAO_0002000 bao:BAO_0000998 ; # "has measured entity" -> "Probenecid" || bao:BAO_0003102 <http://purl.obolibrary.org/obo/CHEBI_35222> ; # "has role" -> "inhibitor"
bao:BAO_0002000 bao:BAO_0001030 ; # "has measured entity" -> "Thapsigargin" || bao:BAO_0003102 bao:BAO_00020138 ; # "has role" -> "potentiator"
bao:BA0_0090012 "Beta lactamase" ; # "has participant" -> "Beta lactamase"
bao:BAO_0002004 <http://purl.obolibrary.org/obo/CLO_0002421> ; # "has cell line" -> "CHO cell"
bao:BAO_0002921 <http://purl.obolibrary.org/obo/NCBITaxon_562> ; # "has organism" -> "Escherichia coli"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "948669" ; # "gene ID" -> "948669"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "P00811" ; # "uniprot ID" -> "P00811"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "562" ; # "NCBI taxonomy ID" -> "562"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "10% v/v dialyzed fetal bovine serum" ; # "material entity culture serum" -> "10% v/v dialyzed fetal bovine serum" || bao:BAO_0003102 bao:BAO_0002596 ; # "has role" -> "culture serum"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "\"DMEM with GlutaMAX-I containing 10% v/v dialyzed FBS, 0.1 mM NEAA, 1 mM Sodium Pyruvate, 25 mM HEPES, 100 microg/mL Zeocin and 1X penicillin-streptomycin-neomycin\"" ; # "material entity culture medium" -> ""DMEM with GlutaMAX-I containing 10% v/v dialyzed FBS, 0.1 mM NEAA, 1 mM Sodium Pyruvate, 25 mM HEPES, 100 microg/mL Zeocin and 1X penicillin-streptomycin-neomycin"" || bao:BAO_0003102 bao:BAO_0000114 ; # "has role" -> "culture medium"
bao:BAO_0002922 "\"DMEM with GlutaMAX-I containing 10% v/v dialyzed FBS, 0.1 mM NEAA, 1 mM Sodium Pyruvate, 25 mM HEPES, and 1X penicillin-streptomycin-neomycin\"" ; # "has assay medium" -> ""DMEM with GlutaMAX-I containing 10% v/v dialyzed FBS, 0.1 mM NEAA, 1 mM Sodium Pyruvate, 25 mM HEPES, and 1X penicillin-streptomycin-neomycin""
bao:BAO_0002922 bao:BAO_0000596 ; # "has assay medium" -> "assay medium"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "10% v/v dialyzed fetal bovine serum" ; # "material entity assay serum" -> "10% v/v dialyzed fetal bovine serum"
bao:BAO_0002923 bao:BAO_0002597 ; # "has assay serum" -> "assay serum"
bao:BAO_0000212 bao:BAO_0000246 ; # "has assay method" -> "stable transfection"
bao:BAO_0000550 "Expressing beta-lactamase (BLA) gene under the control of the NFAT promoter (NFAT-BLA)" ; # "DNA construct" -> "Expressing beta-lactamase (BLA) gene under the control of the NFAT promoter (NFAT-BLA)"
bao:BAO_0003105 "galanin receptor 2" ; # "has function" -> "galanin receptor 2"
bao:BAO_0002921 <http://purl.obolibrary.org/obo/NCBITaxon_9606> ; # "has organism" -> "Homo sapiens"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "8811" ; # "construct gene ID" -> "8811"
bao:BAO_0002662 bao:BAO_0002157 ; # "has quality" -> "native form"
bao:BAO_0003105 bao:BAO_00020151 ; # "has function" -> "artificial regulatory region"
bao:BAO_0003105 "Nuclear Factor of Activated T-cells" ; # "has function" -> "Nuclear Factor of Activated T-cells"
bao:BAO_0003105 bao:BAO_0000751 ; # "has function" -> "Beta-lactamase" || bao:BAO_0003102 bao:BAO_0002656 ; # "has role" -> "reporter gene"
bao:BAO_0002897 bao:BAO_0000360 ; # "has preparation method" -> "recombinant expression"
bao:BA0_0090012 bao:BAO_0000751 ; # "has participant" -> "Beta-lactamase"
bao:BAO_0002000 bao:BAO_0002001 ; # "has measured entity" -> "measured entity"
bao:BAO_0002857 bao:BAO_0000261 ; # "has signal direction" -> "signal decrease corresponding to inhibition"
bao:BAO_0000308 bao:BAO_0000958 ; # "has assay kit" -> "LiveBLAzer FRET - B/G Loading Kit"
bao:BAO_0000308 bao:BAO_0000248 ; # "has assay kit" -> "assay Kit"
bao:BAO_0000737 bao:BAO_0000677 ; # "has manufacturer" -> "Invitrogen" || bao:BAO_0003102 bao:BAO_0002626 ; # "has role" -> "biologics and screening manufacturer"
bao:BA0_0090012 bao:BAO_0000176 ; # "has participant" -> "small molecule" || bao:BAO_0003102 bao:BAO_00020137 ; # "has role" -> "perturbagen"
bao:BAO_0000212 bao:BAO_0000574 ; # "has assay method" -> "single perturbagen"
bao:BAO_0000648 bao:BAO_0000733 ; # "compound library" -> "MLSMR library"
bao:BAO_0002865 bao:BAO_0000701 ; # "uses detection instrument" -> "EnVision Multilabel Reader"
bao:BAO_0000737 bao:BAO_0000297 ; # "has manufacturer" -> "Perkin Elmer" || bao:BAO_0003102 bao:BAO_0002628 ; # "has role" -> "instrumentation manufacturer"
bao:BAO_0002917 "405 nanometer" ; # "has excitation wavelength value" -> "405 nanometer"
bao:BAO_0002918 "460 nanometer" ; # "has emission wavelength value" -> "460 nanometer"
bao:BAO_0002918 "535 nanometer" ; # "has emission wavelength value" -> "535 nanometer"
bao:BAO_0000337 bao:BAO_0000201 ; # "has percent response" -> "percent inhibition"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "1" ; # "PubChem TID" -> "1"
bao:BAO_0000182 <http://purl.org/obo/owl/UO#UO_0000187> ; # "has response unit" -> "percent"
bao:BAO_0002666 "4.2" ; # "has concentration value" -> "4.2"
bao:BAO_0000183 <http://purl.org/obo/owl/UO#UO_0000064> ; # "has concentration unit" -> "micromolar"
bao:BAO_0002787 "1" ; # "has concentration-point number" -> "1"
bao:BAO_0002845 "3" ; # "has repetition point-number" -> "3"
bao:BAO_0000196 bao:BAO_0000441 ; # "has mode of action" -> "competitive binding"
bao:BAO_0002864 bao:BAO_0000533 ; # "has repetition throughput" -> "multiple repetition"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "mp" ; # "Annotated by" -> "mp"
